agilon health, inc.
AGL
$86.39
$5.827.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 48.92M | -188.88M | -- | -104.37M | 12.11M |
| Total Depreciation and Amortization | 6.79M | -6.73M | -- | 7.32M | 6.88M |
| Total Amortization of Deferred Charges | -- | 13.70M | -- | -- | -- |
| Total Other Non-Cash Items | -23.55M | 78.71M | -- | 9.09M | -12.18M |
| Change in Net Operating Assets | -8.43M | 82.67M | -- | 52.88M | -38.79M |
| Cash from Operations | 23.73M | -20.54M | -- | -35.09M | -31.99M |
| Capital Expenditure | -3.10M | -2.97M | -- | -3.25M | -3.85M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.37M | 25.55M | -- | 73.71M | -19.24M |
| Cash from Investing | 19.27M | 22.58M | -- | 70.46M | -23.09M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.50M | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.65M | -17.00K | -- | -2.58M | -161.00K |
| Cash from Financing | -5.15M | -17.00K | -- | -2.58M | -161.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.85M | 2.03M | -- | 32.79M | -55.24M |